Role of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography in early and late therapy assessment of patients with advanced Hodgkin lymphoma treated with bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine and prednisone.
第一作者:
Jana,Markova
第一单位:
Department of Clinical Hematology, University Hospital Kralovske Vinohrady, Third Faculty of Medicine, Charles University, Prague, Czech Republic. markova@fnkv.cz
作者:
医学主题词
青少年(Adolescent);成年人(Adult);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);博来霉素(Bleomycin);环磷酰胺(Cyclophosphamide);多柔比星(Doxorubicin);用药计划表(Drug Administration Schedule);依托泊甙(Etoposide);女(雌)性(Female);氟脱氧葡萄糖F18(Fluorodeoxyglucose F18);随访研究(Follow-Up Studies);霍奇金病(Hodgkin Disease);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);男(雄)性(Male);中年人(Middle Aged);正电子发射断层显像术(Positron-Emission Tomography);泼尼松(Prednisone);丙卡巴肼(Procarbazine);预后(Prognosis);放射性药物(Radiopharmaceuticals);时间因素(Time Factors);治疗结果(Treatment Outcome);长春新碱(Vincristine);青年人(Young Adult)
DOI
10.3109/10428194.2011.603444
PMID
21740300
发布时间
2019-01-16
- 浏览36
Leukemia & lymphoma
64-70页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



